Lead Product(s): INS-3001
Therapeutic Area: Cardiology/Vascular Diseases
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 05, 2020
INS-3001 was found to be a potent and well tolerated inhibitor of pathological soft tissue calcification in preclinical studies.